Genmab A/S (NASDAQ:GMAB) Research Coverage Started at Cowen

Cowen took over coverage of shares from Genmab A/S (NASDAQ:GMAB – Get Rating) in a report published Monday, Briefing.com reports. The company assigned a market perform rating and a price target of $38.00 on the stock. Cowen’s price target indicates a potential upside of 8.02% from the company’s current price. Several other analysts have also … اقرأ المزيد